Back to News
Oct 30, 2025 4:00 PM

Baxter Trims Annual Outlook Again, Stock Hits 52-Week

Baxter International Inc. (NYSE:BAX) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance.

BAX stock is at key technical levels. See the trading setup here

Baxter reported a third-quarter adjusted EPS of 69 cents, surpassing the management guidance of 58-62 cents and the Wall Street estimate of 60 cents.

The medical device maker reported sales of $2.84 billion, up 5% year-over-year on a reported basis and 2% on an operational basis. That's almost in line with the consensus of $2.88 billion.

Also Read: Trump Administration Review Targets Medical Supply Chain Vulnerabilities

Management expected third-quarter sales growth of 6% to 7% on a reported basis and